Effect of Self-administered Transcranial Direct Stimulation in Patients with Major Depressive Disorder: A Randomized, Single-blinded Clinical Trial
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective: In numerous studies that have addressed transcranial direct current stimulation (tDCS) devices, participants visit the hospital regularly and undergo stimulation directed by health professionals. This method has the advantage of being able to deliver accurate stimuli in a controlled environment, but it does not adopt the merits of tDCS portability and applicability. Thus, it may be necessary to investigate how self-administered tDCS treatment at home affects depression- related symptoms. Methods: In this randomized, single-blinded clinical trial, 58 patients with major depressive disorder were assigned to active and sham tDCS stimulation groups, and treatment responses were evaluated biweekly over six weeks. Both active and sham tDCS treatment group were treated with escitalopram. All participants were instructed the protocol and usage of at-home tDCS device, and self-administered tDCS treatment at their home. Results: The beck-depression inventory score decreased significantly as treatment progressed, and the degree of symptom improvement was significantly higher in the active group than in the sham tDCS group. There were no significant differences between the two groups in other indices, including the Hamilton Depression Scale. Conclusion: These results suggest that patient-administered tDCS treatment might be effective in improving subjective symptoms of depression.
Abstract
Objective: In numerous studies that have addressed transcranial direct current stimulation (tDCS) devices, participants visit the hospital regularly and undergo stimulation directed by health professionals. This method has the advantage of being able to deliver accurate stimuli in a controlled environment, but it does not adopt the merits of tDCS portability and applicability. Thus, it may be necessary to investigate how self-administered tDCS treatment at home affects depression- related symptoms. Methods: In this randomized, single-blinded clinical trial, 58 patients with major depressive disorder were assigned to active and sham tDCS stimulation groups, and treatment responses were evaluated biweekly over six weeks. Both active and sham tDCS treatment group were treated with escitalopram. All participants were instructed the protocol and usage of at-home tDCS device, and self-administered tDCS treatment at their home. Results: The beck-depression inventory score decreased significantly as treatment progressed, and the degree of symptom improvement was significantly higher in the active group than in the sham tDCS group. There were no significant differences between the two groups in other indices, including the Hamilton Depression Scale. Conclusion: These results suggest that patient-administered tDCS treatment might be effective in improving subjective symptoms of depression.
참고문헌 (39)
- Dufouil C, "Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration", Am J Epidemiol, 144, pp.634~641 (1996)
- Belmaker RH, "Major depressive disorder", N Engl J Med, 358, pp.55~68 (2008)
- Kessler RC, "The epidemiology of depression across cultures", Annu Rev Public Health, 34, pp.119~138 (2013)
- The survey of mental disorders in Korea, "Samsung Medical Center", Ministry of Health and Welfare, ~ (2016)
- Marcus SC, "National trends in the treatment for depression from 1998 to 2007", Arch Gen Psychiatry, 67, pp.1265~1273 (2010)
- Davidson JR, "Major depressive disorder treatment guidelines in America and Europe", J Clin Psychiatry, 71(Suppl E1), pp.e04~ (2010)
- Ohayon MM, "Epidemiology of depression and its treatment in the general population", J Psychiatr Res, 41, pp.207~213 (2007)
- Givens JL, "Older patients’ aversion to antidepressants. A qualitative study", J Gen Intern Med, 21, pp.146~151 (2006)
- Trivedi MH, "Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression", CNS Spectr, 12(8 Suppl 13), pp.1~27 (2007)
- 박준혁, "한국의 우울증 역학에 대한 고찰", 대한의사협회지, 54(4), pp.362~369 (2011), 대한의사협회
- Roman A, "Effect of combined treatment with paroxetine and transcranial magnetic stimulation(TMS)on the mitogen-induced proliferative response of rat lymphocytes", Pol J Pharmacol, 54, pp.633~639 (2002)
- Gonzalez-Pinto A, "Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression", J Neuropsychiatry Clin Neurosci, 14, pp.206~209 (2002)
- Brunoni AR, "Trial of electrical direct-current therapy versus escitalopram for depression", N Engl J Med, 376, pp.2523~2533 (2017)
- Brunoni AR, "Transcranial direct current stimulation for the treatment of major depressive disorder : a summary of preclinical, clinical and translational findings", Prog Neuropsychopharmacol Biol Psychiatry, 39, pp.9~16 (2012)
- Shiozawa P, "Transcranial direct current stimulation for major depression : an updated systematic review and metaanalysis", Int J Neuropsychopharmacol, 17, pp.1443~1452 (2014)
- Brunoni AR, "Transcranial direct current stimulation for acute major depressive episodes : meta-analysis of individual patient data", Br J Psychiatry, 208, pp.522~531 (2016)
- Bech P, "Effective dose of escitalopram in moderate versus severe DSM-IV major depression", Pharmacopsychiatry, 39, pp.128~134 (2006)
- Williams JB, "A structured interview guide for the Hamilton Depression Rating Scale", Arch Gen Psychiatry, 45, pp.742~747 (1988)
- Svanborg P, "A comparison between the Beck Depression Inventory(BDI)and the self-rating version of the Montgomery Asberg Depression Rating Scale(MADRS)", J Affect Disord, 64, pp.203~216 (2001)
- Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)
- Beck AT, "Psychometric properties of the Beck Depression Inventory : twenty-five years of evaluation", Clin Psychol Rev, 8, pp.77~100 (1988)
- Lam RW, "Psychometric validation of Perceived Deficits Questionnaire-Depression(PDQ-D)in patients with major depressive disorder(MDD)", Value Health, 16, pp.A330~ (2013)
- 김재민, "Development of a Korean Version of the Perceived Deficits Questionnaire-Depression for Patients with Major Depressive Disorder", Clinical Psychopharmacology and Neuroscience, 14(1), pp.26~32 (2016), 대한정신약물학회
- Maier W, "The Hamilton Anxiety Scale : reliability, validity and sensitivity to change in anxiety and depressive disorders", J Affect Disord, 14, pp.61~68 (1988)
- Fydrich T, "Reliability and validity of the beck anxiety inventory", J Anxiety Disord, 6, pp.55~61 (1992)
- "State-trait anxiety inventory for adults (STAI-AD)" (1983)[URL]
- Jermann F, "Cognitive Emotion Regulation Questionnaire(CERQ)", Eur J Psychol Assess, 22, pp.126~131 (2006)
- Connor KM, "Development of a new resilience scale : the Connor-Davidson Resilience Scale(CD-RISC)", Depress Anxiety, 18, pp.76~82 (2003)
- Klein LE, "Diagnosing dementia. Univariate and multivariate analyses of the mental status examination", J Am Geriatr Soc, 33, pp.483~488 (1985)
- Gi Jeong Yun, "The Effects of Transcranial Direct-Current Stimulation on Cognition in Stroke Patients", 대한뇌졸중영문학회지, 17(3), pp.354~358 (2015), 대한뇌졸중학회
- Kalu UG, "Transcranial direct current stimulation in the treatment of major depression : a meta-analysis", Psychol Med, 42, pp.1791~1800 (2012)
- Loo CK, "Transcranial direct current stimulation for depression : 3-week, randomised, sham-controlled trial", Br J Psychiatry, 200, pp.52~59 (2012)
- Blumberger DM, "A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression", Front Psychiatry, 3, pp.74~ (2012)
- Loo CK, "International randomized-controlled trial of transcranial Direct Current Stimulation in depression", Brain Stimul, 11, pp.125~133 (2018)
- Bolognini N, "Immediate and sustained effects of 5-day transcranial direct current stimulation of the motor cortex in phantom limb pain", J Pain, 16, pp.657~665 (2015)
- Meron D, "Transcranial direct current stimulation(tDCS)in the treatment of depression : systematic review and meta-analysis of efficacy and tolerability", Neurosci Biobehav Rev, 57, pp.46~62 (2015)
- Horvath JC, "Quantitative review finds no evidence of cognitive effects in healthy populations from single-session transcranial direct current stimulation(tDCS)", Brain Stimul, 8, pp.535~550 (2015)
- Martin DM, "Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder : an individual patient data meta-analysis of randomised, sham-controlled trials", Neurosci Biobehav Rev, 90, pp.137~145 (2018)
- D’Urso G, "Clinical predictors of acute response to transcranial direct current stimulation(tDCS)in major depression", J Affect Disord, 219, pp.25~30 (2017)